EGRIFTA SV® is distributed in the United States only.
The news last week that three people in Sydney were hospitalized with botulism after receiving botox injections has raised ...
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Omvoh works to reduce inflammation within the gastrointestinal ...
Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...
News Medical on MSN2d
NIH clinical trial examines investigational therapy for dengueA clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
NIH-funded clinical trial will evaluate new dengue therapeutic: Bethesda, Maryland Thursday, February 13, 2025, 11:00 Hrs [IST] A clinical trial supported by the National Institut ...
Hosted on MSN6d
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15, a ...
Silverberg, J.I., Rosmarin, D., Chovatiya, R. et al. The regulatory T cell-selective interleukin-2 receptoragonist rezpegaldesleukin in the treatment of inflammatory ...
JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...
Sydney, Feb 7 (The Conversation) The news last week that three people in Sydney were hospitalised with botulism after receiving botox injections has raised ... botulinum in infants specifically.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback